This is the logo of the provider
ADA 2025 20 - 23 June 2025

Effect of Type 2 Diabetes Characteristics on Semaglutide Treatment in People with Type 2 Diabetes and Peripheral Artery Disease: A Post-Hoc Analysis of the STRIDE Trial

Authors :

Neda Rasouli1; Ecenur G. Arslan2; Andrei-Mircea Catarig2; Kim Houlind3,4; Bernhard Ludvik5; Joakim Nordanstig6; Harald Sourij7; Sebastian Thomas8; Subodh Verma9; Marc P. Bonaca10;

Affiliations
View Details Hide Details
This is the logo of the provider
{{ getPageNum(PDFPage) }}
Keywords
Cardiovascular Disease
Congress oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)